Susquehanna International Group’s Immunocore IMCR Stock Holding History

Susquehanna International Group’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-68,300	Closed	-$2.48M	–	12934
2025 Q3	$2.48M	Sell	68,300 -206,700	-75%	-$7.02M	﹤0.01%	5332
2025 Q2	$8.63M	Buy	275,000 +252,200	+1,106%	+$7.83M	﹤0.01%	3041
2025 Q1	$676K	Buy	+22,800	New	+$684K	﹤0.01%	8230
2024 Q4	–	Sell	-203,900	Closed	-$6.35M	–	12671
2024 Q3	$6.35M	Buy	+203,900	New	+$7.42M	﹤0.01%	3218
2024 Q2	–	Sell	-26,600	Closed	-$1.73M	–	12599
2024 Q1	$1.73M	Buy	26,600 +3,600	+16%	+$247K	﹤0.01%	5677
2023 Q4	$1.57M	Buy	+23,000	New	+$1.2M	﹤0.01%	5885
2023 Q3	–	Sell	-44,000	Closed	-$2.64M	–	12444
2023 Q2	$2.64M	Sell	44,000 -7,300	-14%	-$417K	﹤0.01%	4600
2023 Q1	$2.54M	Buy	51,300 +14,500	+39%	+$815K	﹤0.01%	4651
2022 Q4	$2.1M	Sell	36,800 -67,600	-65%	-$3.8M	﹤0.01%	4609
2022 Q3	$4.9M	Buy	104,400 +14,600	+16%	+$696K	﹤0.01%	3182
2022 Q2	$3.35M	Buy	+89,800	New	+$2.92M	﹤0.01%	3874

Other funds holding IMCR

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Susquehanna International Group's IMCR Position: Q1 2026 in Review

Susquehanna International Group reduced its Immunocore (IMCR) stake by 75% in Q1 2026, selling an estimated $859K and leaving 8,622 shares worth $260K. The position accounts for ﹤0.01% of the portfolio, ranked #11178.

Susquehanna International Group first reported a position in IMCR in Q2 2022 and has held it in 10 quarters since. The position peaked at $3.49M in Q3 2024. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

Susquehanna International Group held 8,622 shares of Immunocore worth $260K as of Q1 2026.
Susquehanna International Group sold 26,566 Immunocore shares in Q1 2026, an estimated $859K.
Immunocore made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11178 holding.
Susquehanna International Group first reported a position in Immunocore in Q2 2022 and has held it in 10 quarters since.
Susquehanna International Group's Immunocore position peaked at $3.49M in Q3 2024.
142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.